Pulse Biosciences Inc (PLSE) Fundamentals

Pulse Biosciences Inc is a medical therapy company that pursues the commercial introduction of its proprietary CellFX System utilizing its patent-protected Nano-Pulse Stimulation (NPS) platform technology. Through its proprietary CellFX System, the company can deliver a cell-focused effect on dysfunctional cells while preserving surrounding non-cellular tissue, a combination that may potentially lead to both improved efficacy and less collateral tissue damage. Substantial revenue is generated from North America Majorly due to the sale of systems.
SHARE INFORMATION
Market Cap$ 50,663,876
Shares Outstanding29,802,280
Float14,098,452
Percent Float47.31%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 1,418,000
Latest Fiscal EPS$ -2.29
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions145
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months233,361
Institutional Holdings Percent26.2%
Institutional Sold Previous 3 Months167,663
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months325,961
Insider Holdings Percent51.2
Insider Sold Previous 3 Months-
Insider Shares Owned15,257,823
TRADING INFO
52 Week High$ 29.16
52 Week Low$ 1.41
52 Week High Change$ -90.09
21 Day Moving Average$ 2.7538
21 Day Extended Moving Average$ 2.692
50 Day Moving Average$ 3.78
50 Day Extended Moving Average$ 4.161
200 Day Moving Average$ 14.3405
200 Day Extended Moving Average$ 11.4055
10 Day Average Volume207,767
20 Day Average Volume366,715
30 Day Average Volume329,550
50 Day Average Volume253,043
Alpha-0.027887
Beta1.8916
Standard Deviation0.232256
R20.148628
7 Day Price Change$ -0.71
7 Day Percent Change-29.46%
21 Day Price Change$ -1.48
21 Day Percent Change-46.54%
30 Day Price Change$ -2.02
30 Day Percent Change-54.3%
Month to Date Price Change$ -0.80
Month to Date Percent Change-32.0%
Quarter to Date Price Change$ -3.16
Quarter to Date Percent Change-65.02%
180 Day Price Change$ -19.93
180 Day Percent Change-92.14%
200 Day Price Change$ -19.93
200 Day Percent Change-92.14%
Year to Date Price Change$ -13.11
Year to Date Percent Change-88.52%

Pulse Biosciences Inc (PLSE) Key Ratios

PROFITABILITY
EBIT Margin-4,443.9%
EBITDA Margin-4,363.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin-38.8%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 1,418,000
Revenue Per Share$ 0.0476
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.70
Total Debt To Equity0.30
Int Coverage0.00
Current Ratio4.30
Leverage Ratio1.40
Quick Ratio3.40
Long Term Debt To Capital0.22
VALUATION MEASURES
PE Ratio-0.70
Enterprise Value$ 33,299,876
Price to Sales35.7291
Price to Free Cash-1.20
PE High Last 5 Years-9.00
Price To Book1.40
Price To Cash Flow0.00
PE Low Last 5 Years-7.50
Price to Tangible Book1.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover46.50
Invoice Turnover0.60
Assets Turnover0.00
Return Assets-137.36
Return on Equity-223.36
Return on Capital-156.82

Pulse Biosciences Inc (PLSE) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorDeloitte & Touche LLP
CEODarrin R. Uecker
Emplyoees142
Last AuditUE
CIK0001625101
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSSurgical Appliance and Supplies Manufacturing(339113)
CONTACT INFO
Address3957 Point Eden Way
Hayward, CA 94545
Websitehttps://www.pulsebiosciences.com
Facsimile-
Telephone+1 510 906-4600
EmailIR@pulsebiosciences.com


Your Recent History
NASDAQ
PLSE
Pulse Bios..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.